Related references
Note: Only part of the references are listed.Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years
Fanny E. R. Vuik et al.
GUT (2019)
Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer
Tian-An Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Global patterns and trends in colorectal cancer incidence in young adults
Rebecca L. Siegel et al.
GUT (2019)
Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019 Featured Updates to the NCCN Guidelines
Samir Gupta et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2019)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report
Mev Dominguez-Valentin et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2019)
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers
Guo-Chen Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
The Heterogeneity Between Lynch-Associated and Sporadic MMR Deficiency in Colorectal Cancers
Guo-Chen Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database
Pal Moller et al.
GUT (2017)
Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency
R. Cohen et al.
EUROPEAN JOURNAL OF CANCER (2017)
Response to Chemotherapy and Prognosis in Metastatic Colorectal Cancer With DNA Deficient Mismatch Repair
Alexandra Khichfy Alex et al.
CLINICAL COLORECTAL CANCER (2017)
Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome
Laura Renkonen-Sinisalo et al.
DISEASES OF THE COLON & RECTUM (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
Sigurdis Haraldsdottir et al.
GENETICS IN MEDICINE (2016)
Survival in familial colorectal cancer: a Danish cohort study
Charlotte Kvist Lautrup et al.
FAMILIAL CANCER (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Milestones of Lynch syndrome: 1895-2015
Henry T. Lynch et al.
NATURE REVIEWS CANCER (2015)
The Clinical Utility of the Combination of T Stage and Venous Invasion to Predict Survival in Patients Undergoing Surgery for Colorectal Cancer
Campbell S. D. Roxburgh et al.
ANNALS OF SURGERY (2014)
Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome
Louise Klarskov et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Familial colorectal cancer type X: polyp burden and cancer risk stratification via a family history score
Poh-Koon Koh et al.
ANZ JOURNAL OF SURGERY (2011)
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy
Frank A. Sinicrope et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
M. Koopman et al.
BRITISH JOURNAL OF CANCER (2009)
Genomic and epigenetic instability in colorectal cancer pathogenesis
William M. Grady et al.
GASTROENTEROLOGY (2008)
Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
H Hampel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
A Hemminki et al.
GASTROENTEROLOGY (2000)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
R Gryfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
